Although beyond the scope of the present study, it has been found that the overactivation of AMPK has been observed in several neurodegenerative diseases, such as Alzheimer’s disease, progressive supranuclear palsy, corticobasal degeneration, Pick’s disease, Parkinson’s disease, and others [7]. Here, PRKAA1 is linked to neurodegenerative disease.